Eargo 6 vs Lexie B3

The Eargo 6 is a premium-priced OTC hearing aid ($2,250) that earns a B grade with a SoundScore of 3.4/5 in our lab testing. This invisible-in-ear device ranks #42 of 65 OTC hearing aids tested, placing it in the top 63% of its category. In our standardized testing, the Eargo 6 demonstrates solid speech clarity in quiet environments, scoring 3.3/5—notably 0.53 points above the OTC category average. Own-voice comfort also performs above category average at 2.9/5, which may benefit users sensitive to the sound of their own voice. However, the device shows limitations in challenging listening situations, with speech-in-noise performance scoring 1.0/5, falling 0.48 points below the category average. A significant limitation is music streaming, which scores 0.0/5—well below the category average by 1.92 points. Users who prioritize streaming audio content should consider alternatives. Feedback handling scores 3.3/5, which is solid in absolute terms though 1.24 points below the category average of 4.54/5. The Eargo 6 may appeal to users prioritizing a completely invisible form factor and solid quiet-environment performance. However, at its premium price point, alternatives like the Sony CRE-C10 offer stronger overall performance at a lower price. The rechargeable battery adds convenience, but buyers should weigh the device's limitations in noise and streaming against its aesthetic benefits.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.